Total Debt Summary of Exelixis, Inc.

Exelixis, Inc.'s latest annual total debt in 2023 was 189.94 Million USD , down -0.12% from previous year.
Exelixis, Inc.'s latest quarterly total debt in 2024 Q1 was 201.46 Million USD , up 6.07% from previous quarter.
Exelixis, Inc. reported annual total debt of 190.17 Million USD in 2022, up 270.9% from previous year.
Exelixis, Inc. reported annual total debt of 51.27 Million USD in 2021, up 4.45% from previous year.
Exelixis, Inc. reported quarterly total debt of 190.85 Million USD for 2023 Q3, down -1.97% from previous quarter.
Exelixis, Inc. reported quarterly total debt of 186.94 Million USD for 2023 Q1, down -1.69% from previous quarter.

Annual Total Debt Chart of Exelixis, Inc. (2023 - 1998)

Historical Annual Total Debt of Exelixis, Inc. (2023 - 1998)

Year	Total Debt	Total Debt Growth
2023	189.94 Million USD	-0.12%
2022	190.17 Million USD	270.9%
2021	51.27 Million USD	4.45%
2020	49.08 Million USD	-3.26%
2019	50.73 Million USD	316.64%
2018	12.17 Million USD	-16.19%
2017	14.53 Million USD	-92.32%
2016	189.12 Million USD	-50.42%
2015	381.43 Million USD	5.47%
2014	361.65 Million USD	4.15%
2013	347.23 Million USD	3.43%
2012	335.73 Million USD	84.96%
2011	181.51 Million USD	-12.92%
2010	208.45 Million USD	161.83%
2009	79.61 Million USD	-32.34%
2008	117.68 Million USD	-3.16%
2007	121.51 Million USD	-0.11%
2006	121.65 Million USD	-18.27%
2005	148.84 Million USD	1.01%
2004	147.35 Million USD	32.65%
2003	111.08 Million USD	50.25%
2002	73.93 Million USD	51.06%
2001	48.94 Million USD	227.38%
2000	14.95 Million USD	12.41%
1999	13.3 Million USD	0.0%
1998	- USD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	201.46 Million USD	6.07%
2023 Q3	190.85 Million USD	-1.97%
2023 Q1	186.94 Million USD	-1.69%
2023 Q2	194.69 Million USD	4.14%
2023 Q4	189.94 Million USD	-0.48%
2023 FY	189.94 Million USD	-0.12%
2022 Q3	159.83 Million USD	-0.73%
2022 Q2	161.01 Million USD	217.99%
2022 Q1	50.63 Million USD	-1.24%
2022 Q4	190.17 Million USD	18.98%
2022 FY	190.17 Million USD	270.9%
2021 Q3	52.25 Million USD	-1.82%
2021 Q4	51.27 Million USD	-1.88%
2021 Q2	53.22 Million USD	0.73%
2021 FY	51.27 Million USD	4.45%
2021 Q1	52.83 Million USD	7.64%
2020 Q2	48.33 Million USD	0.94%
2020 Q1	47.88 Million USD	-5.63%
2020 FY	49.08 Million USD	-3.26%
2020 Q3	47.62 Million USD	-1.46%
2020 Q4	49.08 Million USD	3.07%
2019 Q1	19.95 Million USD	63.89%
2019 Q2	22.54 Million USD	12.95%
2019 FY	50.73 Million USD	316.64%
2019 Q3	23.7 Million USD	5.15%
2019 Q4	50.73 Million USD	114.04%
2018 Q2	20.64 Million USD	0.0%
2018 FY	12.17 Million USD	-16.19%
2018 Q4	12.17 Million USD	-3.49%
2018 Q3	12.61 Million USD	-38.88%
2018 Q1	- USD	-100.0%
2017 Q2	- USD	-100.0%
2017 FY	14.53 Million USD	-92.32%
2017 Q4	14.53 Million USD	0.0%
2017 Q3	- USD	0.0%
2017 Q1	113.34 Million USD	-40.07%
2016 Q3	190.85 Million USD	-51.81%
2016 Q4	189.12 Million USD	-0.91%
2016 Q1	388.65 Million USD	1.89%
2016 Q2	396.05 Million USD	1.9%
2016 FY	189.12 Million USD	-50.42%
2015 Q2	371.22 Million USD	0.76%
2015 Q3	377.88 Million USD	1.79%
2015 Q4	381.43 Million USD	0.94%
2015 Q1	368.43 Million USD	1.87%
2015 FY	381.43 Million USD	5.47%
2014 FY	361.65 Million USD	4.15%
2014 Q4	361.65 Million USD	1.81%
2014 Q1	343.01 Million USD	-1.21%
2014 Q3	355.21 Million USD	1.79%
2014 Q2	348.97 Million USD	1.74%
2013 Q1	330.85 Million USD	-1.45%
2013 FY	347.23 Million USD	3.43%
2013 Q4	347.23 Million USD	1.65%
2013 Q3	341.59 Million USD	1.62%
2013 Q2	336.13 Million USD	1.6%
2012 Q3	335.29 Million USD	83.52%
2012 FY	335.73 Million USD	84.96%
2012 Q4	335.73 Million USD	0.13%
2012 Q1	182.06 Million USD	0.3%
2012 Q2	182.69 Million USD	0.35%
2011 Q1	208.02 Million USD	-0.21%
2011 FY	181.51 Million USD	-12.92%
2011 Q4	181.51 Million USD	-13.55%
2011 Q3	209.95 Million USD	-0.21%
2011 Q2	210.39 Million USD	1.13%
2010 Q2	236.14 Million USD	209.21%
2010 Q1	76.37 Million USD	-4.08%
2010 Q3	234.91 Million USD	-0.52%
2010 FY	208.45 Million USD	161.83%
2010 Q4	208.45 Million USD	-11.26%
2009 Q4	79.61 Million USD	-25.2%
2009 FY	79.61 Million USD	-32.34%
2009 Q2	110.09 Million USD	-3.21%
2009 Q1	113.75 Million USD	-3.34%
2009 Q3	106.43 Million USD	-3.32%
2008 Q4	117.68 Million USD	-4.62%
2008 FY	117.68 Million USD	-3.16%
2008 Q2	127.86 Million USD	8.47%
2008 Q3	123.37 Million USD	-3.51%
2008 Q1	117.88 Million USD	-2.99%
2007 FY	121.51 Million USD	-0.11%
2007 Q4	121.51 Million USD	8.14%
2007 Q3	112.36 Million USD	-2.58%
2007 Q2	115.34 Million USD	-3.2%
2007 Q1	119.15 Million USD	-2.05%
2006 Q2	114.84 Million USD	-22.58%
2006 Q1	148.33 Million USD	-0.34%
2006 Q4	121.65 Million USD	8.14%
2006 FY	121.65 Million USD	-18.27%
2006 Q3	112.49 Million USD	-2.05%
2005 Q2	147.27 Million USD	2.98%
2005 Q3	144.71 Million USD	-1.74%
2005 Q1	143.01 Million USD	-2.95%
2005 FY	148.84 Million USD	1.01%
2005 Q4	148.84 Million USD	2.86%
2004 Q4	147.35 Million USD	31.05%
2004 Q1	107.47 Million USD	-3.25%
2004 Q2	106.98 Million USD	-0.46%
2004 Q3	112.44 Million USD	5.1%
2004 FY	147.35 Million USD	32.65%
2003 Q3	79.51 Million USD	4.33%
2003 Q2	76.21 Million USD	3.33%
2003 Q1	73.75 Million USD	-0.24%
2003 Q4	111.08 Million USD	39.71%
2003 FY	111.08 Million USD	50.25%
2002 Q4	73.93 Million USD	48.33%
2002 Q1	49.03 Million USD	0.19%
2002 FY	73.93 Million USD	51.06%
2002 Q2	49.91 Million USD	1.79%
2002 Q3	49.84 Million USD	-0.14%
2001 Q3	50.53 Million USD	2.73%
2001 Q2	49.19 Million USD	305.13%
2001 FY	48.94 Million USD	227.38%
2001 Q4	48.94 Million USD	-3.15%
2001 Q1	12.14 Million USD	-18.78%
2000 FY	14.95 Million USD	12.41%
2000 Q2	12.19 Million USD	-4.54%
2000 Q3	10.07 Million USD	-17.42%
2000 Q1	12.77 Million USD	0.0%
2000 Q4	14.95 Million USD	48.42%
1999 FY	13.3 Million USD	0.0%
1998 FY	- USD	0.0%

Peer Total Debt Comparison of Exelixis, Inc.

Name	Total Debt	Total Debt Difference
BioNTech SE	219.1 Million EUR	13.307%
CureVac N.V.	41.85 Million EUR	-353.777%
Biotest Aktiengesellschaft	689.8 Million EUR	72.464%
Biotest Aktiengesellschaft	689.8 Million EUR	72.464%
BRAIN Biotech AG	4.65 Million EUR	-3976.926%
Formycon AG	29.48 Million EUR	-544.184%
Heidelberg Pharma AG	5.83 Million EUR	-3157.275%
Medigene AG	2.95 Million EUR	-6338.78%

Global Stocks Search

Exelixis, Inc. (EX9.DE)

Total Debt Summary of Exelixis, Inc.

Annual Total Debt Chart of Exelixis, Inc. (2023 - 1998)

Historical Annual Total Debt of Exelixis, Inc. (2023 - 1998)

Peer Total Debt Comparison of Exelixis, Inc.